Sjögren’s Syndrome

Top Story

Few rheumatic adverse events from immune checkpoint inhibitors require discontinuation

November 15, 2018
Blog

Recapping the ACR Review Course: What You May Have Missed This Year

November 8, 2018
I always look forward to the ACR yearly review course for an engaging way to get updates on various topics in the field of rheumatology. It’s also a way to…
Meeting News

Rheumatologists 'must' respond to checkpoint inhibitor problem

October 21, 2018
CHICAGO — Rheumatologists, as well as the rheumatology specialty as a whole, must become more aware of, and develop treatments and guidelines for, the problem of…
In the Journals

Wearable devices linked to increased activity in rheumatic diseases

October 11, 2018
The use of wearable devices that track movement is effective in significantly increasing the amount of and time spent performing moderate to vigorous physical activity…
More Headlines »
CME ABIM MOC

Ace the Case: A 56-year-old Caucasian Female with a 5-year History of Seropositive Rheumatoid Arthritis

There is no commercial support for this activity.

This “Ace the Case” study will discuss treatment options in patients with rheumatoid arthritis who have had an…
More »
Video
Meeting News Coverage

VIDEO: Calabrese highlights important viral studies from ACR 2015

November 11, 2015
More »
CME

Precision Decision: Realistic Cases: A 47-Year-Old Woman With Increasing Pain, Morning Stiffness, and Decreased Ability to Work

This activity is supported by educational grants from AbbVie, Inc.; Amgen; Bristol-Myers Squibb; Pfizer, Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »